| DIALOG/PROGRESS NOTE TEXT |
If the patient (or surrogate) has agreed to the plan regarding whether or
emergencies. If signature informed consent is required for the
life-sustaining treatment(s) in question, it must be obtained before
specific orders are written and treatment is initiated; refer to
{FLD:VA-LST POLICY LINK} for information about the informed consent
process for life-sustaining treatments.
Before DISCONTINUING a life-sustaining treatment that the patient is
currently receiving, you must discuss associated comfort measures and the
risks, benefits, and alternatives, and the patient (or surrogate) must
provide oral informed consent for discontinuing the treatment. Separate
not to limit life-sustaining treatment in the event of cardiopulmonary
active orders must then be written and/or discontinued as appropriate.
arrest, or in circumstances other than cardiopulmonary arrest, they have
given oral informed consent. They should not be asked to provide
signature consent for these decisions. The provider should implement the
decisions by writing Life-Sustaining Treatment orders accordingly.
INITIATING mechanical ventilation, feeding tubes, dialysis, and other
life-sustaining treatments requires informed consent except in
|
